FOX 9 Minneapolis-St. Paul on MSN31m
Cigna sues, wants leeway to tell customers which pharmacies to useA giant healthcare company is suing the State of Minnesota over a state law that is supposed to protect small pharmacies in ...
Mintz’s Health Law and Antitrust teams actively monitor federal and state regulatory and legislative developments in the PBM ...
The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...
At a public meeting held on January 15, 2025, the Federal Trade Commission (FTC) summarized the Second Interim Staff Report (Second Report) ...
The Federal Trade Commission on Jan. 14 published a second interim staff report on the prescription drug middleman industry, ...
The FTC’s investigation into PBM practices began in 2022. Last summer, the agency released a scathing interim report on the industry. It detailed how increasing concentration enabled the three ...
The FTC's first report drew a strong response from the PBM sector, with lawsuits filed in both directions. The FTC has accused the big three of operating a "perverse drug rebate system," while the ...
The biggest pharmacy benefit managers have made efforts to improve relationships with pharmacies, health insurers, employers ...
All three also previously countersued the FTC, and Cigna noted that the reports are based on small subsets of data. Meanwhile, its Express Scripts PBM data shows that specialty generic medications ...
In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...
A bipartisan, bicameral group of lawmakers is calling on the Federal Trade Commission (FTC) to vote in favor of releasing an interim staff report on pharmacy benefit managers (PBM). Sens.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback